|
1
|
Neville A: Lung cancer. BMJ Clin Evid.
2009:pii: 1504. 2009.PubMed/NCBI
|
|
2
|
Chirieac LR and Dacic S: Targeted
therapies in lung cancer. Surg Pathol Clin. 3:71–82. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lan H, Lu H, Wang X and Jin H: MicroRNAs
as potential biomarkers in cancer: Opportunities and challenges.
Biomed Res Int. 2015:1250942015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lai XL, Huang YH, Li YS, Li GN, Wang LP,
Sun R, Ma YS, Feng SY, Chang ZY, Wang XH, et al: Differential
expression profiling of microRNAs in para-carcinoma, carcinoma and
relapse human pancreatic cancer. Clin Transl Oncol. 17:398–408.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pavlakis E, Papaconstantinou I, Gazouli M,
Theodosopoulos T, Karamanolis G, Genatas K and Ladas SD: MicroRNA
gene polymorphisms in pancreatic cancer. Pancreatology. 13:273–278.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Y, VandenBoom TG II, Kong D, Wang Z,
Ali S, Philip PA and Sarkar FH: Up-regulation of miR-200 and
let-7 by natural agents leads to the reversal of
epithelial-to-mesenchymal transition in gemcitabine-resistant
pancreatic cancer cells. Cancer Res. 69:6704–6712. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu J, Ohuchida K, Mizumoto K, Sato N,
Kayashima T, Fujita H, Nakata K and Tanaka M: MicroRNA,
hsa-miR-200c, is an independent prognostic factor in
pancreatic cancer and its upregulation inhibits pancreatic cancer
invasion but increases cell proliferation. Mol Cancer. 9:1692010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mees ST, Mardin WA, Sielker S, Willscher
E, Senninger N, Schleicher C, Colombo-Benkmann M and Haier J:
Involvement of CD40 targeting miR-224 and miR-486 on the
progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol.
16:2339–2350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Y, VandenBoom TG II, Wang Z, Kong D,
Ali S, Philip PA and Sarkar FH: Up-regulation of miR-146a
contributes to the inhibition of invasion of pancreatic cancer
cells. Cancer Res. 70:(Suppl 8). S57032010. View Article : Google Scholar
|
|
11
|
Laurila EM, Sandström S, Rantanen LM,
Autio R and Kallioniemi A: Both inhibition and enhanced expression
of miR-31 lead to reduced migration and invasion of pancreatic
cancer cells. Genes Chromosomes Cancer. 51:557–568. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma C, Nong K, Wu B, Dong B, Bai Y, Zhu H,
Wang W, Huang X, Yuan Z and Ai K: miR-212 promotes pancreatic
cancer cell growth and invasion by targeting the hedgehog signaling
pathway receptor patched-1. J Exp Clin Cancer Res. 33:542014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang F, Tang J, Zhuang X, Zhuang Y, Cheng
W, Chen W, Yao H and Zhang S: MiR-196a promotes pancreatic cancer
progression by targeting nuclear factor kappa-B-inhibitor alpha.
PLoS One. 9:e878972014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Q, Yao Y, Eades G, Liu Z, Zhang Y and
Zhou Q: Downregulation of miR-140 promotes cancer stem cell
formation in basal-like early stage breast cancer. Oncogene.
33:2589–2600. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hwang S, Park SK, Lee HY, Kim SW, Lee JS,
Choi EK, You D, Kim CS and Suh N: miR-140-5p suppresses
BMP2-mediated osteogenesis in undifferentiated human mesenchymal
stem cells. FEBS Lett. 588:2957–2963. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song B, Wang Y, Xi Y, Kudo K, Bruheim S,
Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, et al:
Mechanism of chemoresistance mediated by miR-140 in human
osteosarcoma and colon cancer cells. Oncogene. 28:4065–4074. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kong XM, Zhang GH, Huo YK, Zhao XH, Cao
DW, Guo SF, Li AM and Zhang XR: MicroRNA-140-3p inhibits
proliferation, migration and invasion of lung cancer cells by
targeting ATP6AP2. Int J Clin Exp Pathol. 8:12845–12852.
2015.PubMed/NCBI
|
|
18
|
Yuan Y, Shen Y, Xue L and Fan H: miR-140
suppresses tumor growth and metastasis of non-small cell lung
cancer by targeting insulin-like growth factor 1 receptor. PLoS
One. 8:e736042013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou S, Wang J and Zhang Z: An emerging
understanding of long noncoding RNAs in kidney cancer. J Cancer Res
Clin Oncol. 140:1989–1995. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing miRNA-lncRNA interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu Z, Liu X, Liu L, Deng H, Zhang J, Xu Q,
Cen B and Ji A: Regulation of lncRNA expression. Cell Mol Biol
Lett. 19:561–575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng
R, Wang Y, Huang J, Xu M, Yan J, et al: lncRNA H19/miR-675 axis
represses prostate cancer metastasis by targeting TGFBI. FEBS J.
281:3766–3775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou X, Ye F, Yin C, Zhuang Y, Yue G and
Zhang G: The interaction between miR-141 and lncRNA-H19 in
regulating cell proliferation and migration in gastric cancer. Cell
Physiol Biochem. 36:1440–1452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
96:(Suppl). R40–R44. 2007.PubMed/NCBI
|
|
29
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Green D, Dalmay T and Fraser WD: Role of
miR-140 in embryonic bone development and cancer. Clin Sci.
129:863–873. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J,
Chen L, Xi Z, Teng H, Wang Z, et al: Knockdown of long non-coding
RNA XIST exerts tumor-suppressive functions in human glioblastoma
stem cells by up-regulating miR-152. Cancer Lett. 359:75–86. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang H, Fang F, Chang R and Yang L:
MicroRNA-140-5p suppresses tumor growth and metastasis by targeting
transforming growth factor β receptor 1 and fibroblast growth
factor 9 in hepatocellular carcinoma. Hepatology. 58:205–217. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Profumo V, Doldi V, Gandellini P and
Zaffaroni N: Targeting microRNAs to withstand cancer metastasis.
Methods Mol Biol. 1218:415–437. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen J, Sun D, Chu H, Gong Z, Zhang C,
Gong B, Li Y, Li N and Jiang L: Screening of differential microRNA
expression in gastric signet ring cell carcinoma and gastric
adenocarcinoma and target gene prediction. Oncol Rep. 33:2963–2971.
2015.PubMed/NCBI
|
|
35
|
Chen J, Xie F, Zhang L and Jiang WG: iASPP
is over-expressed in human non-small cell lung cancer and regulates
the proliferation of lung cancer cells through a p53 associated
pathway. BMC Cancer. 10:6942010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gillotin S: iASPP, a potential drug target
in cancer therapy. Leuk Res. 33:1175–1177. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu T, Li L, Yang W, Jia H, Xu M, Bi J, Li
Z, Liu X, Li Z, Jing H, et al: iASPP is important for bladder
cancer cell proliferation. Oncol Res. 19:125–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jia Y, Peng L, Rao Q, Xing H, Huai L, Yu
P, Chen Y, Wang C, Wang M, Mi Y, et al: Oncogene iASPP enhances
self-renewal of hematopoietic stem cells and facilitates their
resistance to chemotherapy and irradiation. FASEB J. 28:2816–2827.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Luan S, Sun L and Huang F: MicroRNA-34a: A
novel tumor suppressor in p53-mutant glioma cell line U251. Arch
Med Res. 41:67–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li S, Liang Z, Xu L and Zou F:
MicroRNA-21: A ubiquitously expressed pro-survival factor in cancer
and other diseases. Mol Cell Biochem. 360:147–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bai AH, Milde T, Remke M, Rolli CG,
Hielscher T, Cho YJ, Kool M, Northcott PA, Jugold M, Bazhin AV, et
al: MicroRNA-182 promotes leptomeningeal spread of non-sonic
hedgehog-medulloblastoma. Acta Neuropathol. 123:529–538. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Y, Ahmad A and Sarkar FH: ASPP and
iASPP: Implication in cancer development and progression. Cell Mol
Biol. 61:2–8. 2015.PubMed/NCBI
|
